Concentration and Preservation of Very Low Abundance Biomarkers in Urine, such as Human Growth Hormone (hGH), by Cibacron Blue F3G-A Loaded Hydrogel Particles.
Urine is a potential source of diagnostic biomarkers for detection of diseases, and is a very attractive means of non-invasive biospecimen collection. Nonetheless, proteomic measurement in urine is very challenging because diagnostic biomarkers exist in very low concentration (usually below the sensitivity of common immunoassays) and may be subject to rapid degradation. Hydrogel nanoparticles functionalized with Cibacron Blue F3G-A (CB) have been applied to address these challenges for urine biomarker measurement. We chose one of the most difficult low abundance, but medically relevant, hormones in the urine: human growth hormone (hGH). The normal range of hGH in serum is 1 to 10 ng/mL but the urine concentration is suspected to be a thousand times less, well below the detection limit (50 pg/mL) of sensitive clinical hGH immunoassays. We demonstrate that CB particles can capture, preserve and concentrate hGH in urine at physiological salt and urea concentrations, so that hGH can be measured in the linear range of a clinical immunometric assay. Recombinant and cadaveric hGH were captured from synthetic and human urine, concentrated and measured with an Immulite chemiluminescent immunoassay. Values of hGH less than 0.05 ng/mL (the Immulite detection limit) were concentrated to 2 ng/mL, with a urine volume of 1 mL. Dose response studies using 10 mL of urine demonstrated that the concentration of hGH in the particle eluate was linearly dependent on the concentration of hGH in the starting solution, and that all hGH was removed from solution. Thus if the starting urine volume is 100 mL, the detection limit will be 0.1 pg/mL. Urine from a healthy donor whose serum hGH concentration was 1.34 ng/mL was studied in order detect endogenous hGH. Starting from a volume of 33 mL, the particle eluate had an hGH concentration of 58 pg/mL, giving an estimated initial concentration of hGH in urine of 0.175 pg/mL. The nanotechnology described here appears to have the desired precision, accuracy and sensitivity to support large scale clinical studies of urine hGH levels.
Fredolini
Claudia
C
Department of Urology, S. Giovanni Bosco Hospital, Torino 10154, Italy.
Meani
Francesco
F
Reeder
K Alex
KA
Rucker
Sally
S
Patanarut
Alexis
A
Botterell
Palma J
PJ
Bishop
Barney
B
Longo
Caterina
C
Espina
Virginia
V
Petricoin
Emanuel F
EF
Liotta
Lance A
LA
Luchini
Alessandra
A
Biomacromolecules. 2008 Jul;9(7):1967-73
18533701
Trends Endocrinol Metab. 2005 May-Jun;16(4):160-6
15860412
J Biochem Biophys Methods. 2001 Oct 30;49(1-3):391-416
11694290
J Chromatogr A. 2008 Sep 19;1204(2):191-6
18538332
J Chromatogr B Biomed Appl. 1996 Dec 6;687(1):201-11
9001966
J Control Release. 2004 Feb 10;94(2-3):303-11
14744482
J Biomater Sci Polym Ed. 2000;11(8):817-31
11211094
Clin Chim Acta. 2007 Jan;375(1-2):49-56
16942764
Nano Lett. 2008 Jan;8(1):350-61
18076201
Clin Chem. 1989 Apr;35(4):577-81
2467763
Br J Sports Med. 2006 Jul;40 Suppl 1:i35-9
16799101
Science. 1982 Oct 29;218(4571):467-9
17808541
Adv Drug Deliv Rev. 2002 Jan 17;54(1):3-12
11755703
J Colloid Interface Sci. 2000 Jul 15;227(2):408-411
10873327
Pediatr Res. 1991 Jun;29(6):619-22
1866220
Am Fam Physician. 2000 Sep 15;62(6):1333-40
11011862
J Mol Recognit. 2006 Jul-Aug;19(4):322-31
16865663
Phys Rev Lett. 1985 Nov 25;55(22):2455-2458
10032149
J Clin Oncol. 2001 Jan 15;19(2):577-83
11208853
BMJ. 1997 Mar 15;314(7083):783-8
9080995
Pituitary. 2007;10(2):115-9
17429592
Biomed Chromatogr. 2006 Feb;20(2):195-9
16161178
Mol Cell Proteomics. 2006 Oct;5(10):1760-71
16837576
Arch Dermatol Res. 2008 Sep;300(8):451-4
18478239
Clin Endocrinol (Oxf). 1994 Feb;40(2):155-70
8137512
Biomaterials. 2005 Jun;26(16):3299-309
15603825
J Proteome Res. 2007 Jul;6(7):2631-9
17518487
Biomed Chromatogr. 2008 Sep;22(9):1001-7
18506902
Asian J Androl. 2008 May;10(3):391-402
18385901
Clin Chim Acta. 2004 Dec;350(1-2):1-16
15530455
Cytokine Growth Factor Rev. 2001 Dec;12(4):375-91
11544106
Cytokine. 2008 Jul;43(1):71-5
18502145
FASEB J. 2005 Mar;19(3):311-30
15746175
Clin Endocrinol (Oxf). 1997 Oct;47(4):447-54
9404443
Asian J Androl. 2008 May;10(3):373-83
18385899
Clin Chem. 2007 Nov;53(11):2002-9
17890442
Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5996-6001
14676125
CMAJ. 2007 Aug 14;177(4):361-8
17698825